Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence.
about
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?Metabotropic Glutamate Receptors 7 within the Nucleus Accumbens are Involved in Relief Learning in Rats.Intracranial self-stimulation to evaluate abuse potential of drugs.Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate HomeostasisMetabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications.
P2860
Q28078759-E5E3018E-A9B7-4723-98BF-90E677669DE0Q30366694-8A8FA296-8484-4C0C-A011-C6B5A74E4EA9Q33845750-97EF0A28-6777-4F3B-B22E-AC2A854AEF4BQ36104010-48C88BEF-9B16-439E-BC23-BE85ED786A4FQ37062538-2F6BB8CB-29AC-4F92-AB08-18A265A9C116Q37062547-93090AE6-6E95-40DB-98F6-B8A16B260094Q38865953-5BF97408-D394-4A05-B946-CF2F8E2ED48A
P2860
Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabotropic glutamate 7 (mGlu ...... eatment of cocaine dependence.
@en
Metabotropic glutamate 7
@nl
type
label
Metabotropic glutamate 7 (mGlu ...... eatment of cocaine dependence.
@en
Metabotropic glutamate 7
@nl
prefLabel
Metabotropic glutamate 7 (mGlu ...... eatment of cocaine dependence.
@en
Metabotropic glutamate 7
@nl
P2093
P2860
P1433
P1476
Metabotropic glutamate 7 (mGlu ...... eatment of cocaine dependence.
@en
P2093
Athina Markou
Zheng-Xiong Xi
P2860
P356
10.1016/J.NEUROPHARM.2012.04.010
P577
2012-04-21T00:00:00Z